Characterization of vascular neuropeptide Y receptors
- 1 January 1992
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 105 (1) , 45-50
- https://doi.org/10.1111/j.1476-5381.1992.tb14208.x
Abstract
1. In the present study we compared neuropeptide Y (NPY) and NPY-related analogues for their ability to activate or bind to vascular NPY receptors in four experimental set-ups. Previous results have suggested the existence of different receptor subtypes, Y1 receptors requiring full-length NPY (1-36) or [Pro34]-NPY, and Y2 receptors recognizing also N-terminally truncated forms of NPY but not [Pro34]-NPY. 2. NPY 1-36 and [Pro34]-NPY dose-dependently increased arterial pressure in the anaesthetized rat with a similar magnitude and potency. NPY 2-36 was much less potent than NPY 1-36. NPY 4-36 and NPY 11-36 were inactive even at a dose as high as 10 nmol kg-1. 3. NPY 1-36, [Pro34]-NPY, NPY 2-36 and NPY 5-36 concentration-dependently increased the coronary resistance in the Langendorff preparation of the rat. NPY 1-36 and [Pro34]-NPY were equipotent, while NPY 2-36 and NPY 5-36 were about 7 and 20 times less potent. At 0.3 microM, NPY 11-36, NPY 20-36 and NPY 22-36 induced a slight contraction while NPY 23-36 was inactive. 4. NPY 1-36, [Pro34]-NPY, NPY 2-36, NPY 4-36, NPY 5-36 and NPY 11-36 evoked concentration-dependent contractions in the isolated inferior caval vein of the rat and guinea-pig. [Pro34]-NPY was more potent than NPY 1-36. NPY 2-36 was equipotent with NPY 1-36, while NPY 4-36, NPY 5-36 and NPY 11-36 were approximately 30 times less potent.5. [Pro34]-NPY was equipotent with NPY 1-36 in displacing the '25I-labelled gut hormone peptide([1251]-PYY) from rat aortic smooth muscle cells, while NPY 2-36 and shorter forms of NPY were much less potent or inactive.6. In caval vein smooth muscle cells of the rat, the displacement pattern was more complex than in aortic smooth muscle cells, in that both [Pro34]-NPY and NPY 13-36 effectively displaced the radioligand,albeit none of them completely.7. In conclusion, the NPY-evoked pressor response in the whole rat and coronary vessels seems to be mediated by vascular Y1 receptors and the binding characteristics of the NPY-related peptides in the aortic smooth muscle cells correspond to a population of such receptors. In the caval vein, the profile of the bioactivity and the binding affinity of the NPY-related peptides suggest a mixed population of Y1/Y2 receptors.Keywords
This publication has 28 references indexed in Scilit:
- Signal Epitopes in the Three‐Dimensional Structure of Neuropeptide YAnnals of the New York Academy of Sciences, 1990
- In vitro method for measurement of cardiac performance and responses to inotropic drugs after experimentally induced myocardial infarction in the ratJournal of Pharmacological Methods, 1989
- Neuropeptide-Y. A peptide found in human coronary arteries constricts primarily small coronary arteries to produce myocardial ischemia in dogs.Journal of Clinical Investigation, 1989
- Potential mechanism of cyclosporine A-induced vascular smooth muscle contraction.Hypertension, 1989
- Y1 and Y2 receptors for neuropeptide YFEBS Letters, 1989
- Synthesis and hypertensive activity of neuropeptide Y fragments and analogs with modified N- or C-termini or D-substitutionsJournal of Medicinal Chemistry, 1989
- The vasoconstrictor effect of neuropeptide Y and related peptides in the guinea pig isolated heartPeptides, 1986
- Neuropeptide Y (NPY) depresses the secretion of 3H‐noradrenaline and the contractile response evoked by field stimulation, in rat vas deferensActa Physiologica Scandinavica, 1984
- Mechanical properties of rat cerebral arteries as studied by a sensitive device for recording of mechanical activity in isolated small blood vessels*Acta Physiologica Scandinavica, 1983
- Neuropeptide Y (NPY)‐like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic functionActa Physiologica Scandinavica, 1982